Diabetes
Testing
Centers™
Go Beyond Blood Sugars®
Join Over 800 Medical Clinics in the U.S. and Advance Diabetes Care
Welcome, Medical Providers!
Diabetes Testing Centers™ is a primary care ancillary service that utilizes innovative technology to identify and intervene in diabetes symptoms early, resulting in longer and healthier lives with fewer complications for people living with diabetes. Our goal since 2010 has to transform primary care and multispecialty clinics into advanced 'Hospital-level care' facilities that provide comprehensive diabetes care. Our approach to fighting diabetes-related conditions involves combining our state-of-the-art programs with a variety of a la carte options, all of which are rooted in holistic health practices.
Diabetes Testing Centers™ stand out for our ability to consolidate a wide range of specialty tests into Primary Care from over 20 different specialties, including Cardiology, Neurology, Endocrinology, Podiatry, etc. This unique offering enables clinics to provide our cutting-edge technologies, which are not typically available in the average medical clinic. Moreover, our Diabetes Testing Center™ offers affordable diabetes care through various models such as Fee-for-Service, Managed Care, and Value-Based Care, all eligible for insurance coverage.
Assessments are Reimbursable
Diabetes and Prediabetes
Consolidated Multispecialty Assessments
Diabetes: A Multispecialty Disease
Complications related to diabetes are health issues that are commonly influenced or associated with diabetes. However, these complications are not limited to individuals with diabetes only. Diabetes is a complex disease affecting major human body organs such as the heart, kidneys, liver, and pancreas. Therefore, managing diabetes is crucial to prevent these complications and maintain overall health. It is essential to understand that diabetes is not just about managing blood sugar levels, but rather, we need to comprehend the profound interplay of various systems in the body and their collective impact on a patient's overall health.
Diabetes can cause a complex network of health problems that are interrelated. This may happen when the body is unable to regulate a healthy glucose level in each organ. It can cause or worsen other conditions, leading to a chain reaction that affects the entire body and results in various health issues. Poorly managed diabetes can trigger a chain of health problems that are interlinked. High blood sugar levels over a prolonged period damage blood vessels throughout the body, causing complications.
Mitigating Morbidities and Mortalities
Evidence-Based Technologies Mitigate Diabetes-Related Conditions
Click here to see which assessments can make a meaningful impact on your practice and patient outcomes.
Exclusive Programs
Turnkey Premium Solutions
At Diabetes Testing Centers™, we stay responsive to emerging healthcare trends and evolving patient requirements, enabling us to provide advanced solutions that address the ever-changing landscape of diabetes management and related health issues. Our Exclusive Programs are comprehensive solutions designed to meet the current healthcare needs and cater to the diverse concerns impacting individuals living with diabetes. These programs provide seamless reimbursement pathways for medical providers, allowing them to focus on delivering exceptional care while ensuring financial stability and operational efficiency within their practices.
Semaglutide (GLP-1) is a program for managing diabetes and achieving medical weight loss.
Sleep ApneaReliefMD™ offers a comfortable, portable, and silent alternative to CPAP using oral appliances.
Painful Neuropathy Program helps to reduce or reverse painful neuropathy using stat-of-the-art technology.
Diabetic Allergy Management helps diabetics to reduce inflammation, pain, and metabolic disorders.
Touchless Wound Therapy offers a turnkey suite of wound care services from the ground up.
At Diabetes Testing Centers™, our mission is to enhance the well-being and quality of life of every patient under a providers care. Through our specialized programs and cutting-edge treatments, we are committed to providing personalized care that yields transformative outcomes with above average reimbursements. With our dedication to innovation and excellence, we invite you to explore the difference that our exclusive programs can bring to your practice and to the lives of your patients.
Our Assessment Average $100 Reimbursements
#1 Program: Semaglutide (GLP-1)
Our Semaglutice (GLP-1) Program Involves Reimbursable Assessments
Reimbursable Semaglutide Program
Diabetes Testing Centers™ is at the forefront with our reimbursable Semaglutide (GLP-1) program by providing accessible and streamlined solutions for assessing diabetes status (for reimbursement support) or self pay options. By utilizing rapid and efficient methods such as point-of-care A1c tests, individuals can receive critical information regarding their glycemic control in just minutes.
Our reimbursable assessments, alongside supplementary screenings, offer invaluable insights into overall health and the potential development of complications associated with diabetes. With this knowledge, patients and healthcare providers can make informed decisions regarding diagnosis and treatment plans tailored to individual needs. Moreover, regular follow-up visits at Diabetes Testing Centers™ play a pivotal role in ensuring effective disease management, facilitating interventions that may lead to the reversal of complications through strategies like weight loss. By prioritizing early detection and personalized care, Diabetes Testing Centers™ strive to empower individuals in their journey toward better health and improved quality of life. Click here to learn more.
Identify Current and Future Complications
Cardiovascular Assessment
Cardiovascular diseases are the leading cause of death among people worldwide.
Prevent Cardiovascular Mortalities
Diabetic Cardiomyopathy is a heart condition that affects people with diabetes. It occurs when diabetes damages the heart muscle, and is not associated with traditional cardiovascular diseases. Type 2 diabetic patients have a 74% higher risk of developing Heart Failure (HF), and those with HF are four times more likely to die. HF often goes undiagnosed in Type 2 diabetics, making it crucial to assess the risk of HF in all diabetic patients and those with multiple comorbidities.
Our CardioANS™ test is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). The CardioANS™ graphs the heartbeat as it moves through systolic and diastolic cycles. It tracks deviations in fingertip pressure caused by flexible arteries and produces a tight, regular graph for stiff arteries. Using a proprietary algorithm, the device analyses arterial pulse wave variations and compares them against a large body of research to accurately assess arterial hardening.
The Framingham Study found that individuals with asymptomatic left ventricular systolic dysfunction (LVSD) at entry had a nearly 5X increase in the risk of developing symptomatic heart failure (HF) compared to those with normal left ventricular function.
Kannel WB, Gordon T, and National Heart Institute (U.S.) (1968) The Framingham study: An epidemiological investigation of cardiovascular disease. Bethesda, MD., United States. Department of Health, Education, and Welfare, National Institutes of Health.
Long COVID-19 Consequences
COVID-19 can have implications for the cardiovascular system, particularly the left ventricle of the heart. Cardiomyopathy in COVID-19 patients refers to a condition where the heart muscle becomes inflamed and weakened due to the viral infection. Many people who have recovered from COVID-19 have reported experiencing lingering cardiovascular symptoms such as abnormal heartbeats, dizziness, and shortness of breath.
It's essential for individuals with long COVID, particularly those with cardiovascular symptoms, to be tested in the primary care setting to determine if there is should be more comprehensive imaging studies like echocardiograms to evaluate the structure and function of the left ventricle. Monitoring the left ventricle's health is crucial for developing targeted interventions and treatment plans to address the lingering cardiovascular effects of the virus.
Features of the tests:
3-minute non-invasive assessment
Measures the overall cardiovascular risk factors (heart attack and stroke)
Measures the left ventricle ejection and contraction power
Measures mental stress, physical stress, and resistance to stress
COVID-19 survivors, regardless of infection severity, are more likely to develop cardiovascular conditions such as heart failure or coronary disease within 30 days post-infection.
Objective Foot Exams
Identify & Measure Small Nerve (A-Delta & C Fibers)
"The Device (DND) Replaces Tuning Forks and Monofilaments..."
Kazu Suzuki DPM, Medical Director of the Tower Wound Care Center at the Cedars-Sinai Medical Towers in Los Angeles, CA; Managing Neuropathy And Pain In Wound Care Patients, Podiatry Today; September 2015; 26-27.
Our Diabetic Neuropathy Device™ (DND) is the first multi-objective, non-invasive tool cleared by the FDA to identify and measure large and small nerve fibers in peripheral extremities.
Identify & Measure Large Nerve (A-Beta Fibers)
2 Tools in 1
Diabetic Neuropathy (DN) is often overlooked as a mortality risk, emphasizing the critical importance of comprehensive assessments and early interventions. The medical community should use modern diagnostic tools instead of outdated ones like tuning forks and monofilaments, which may harm patients - giving false positives and false-negative results. The Diabetic Neuropathy Device™ provides a more accurate and objective approach to early detection and better patient care.
Diabetic Neuropathy Accounts for More Hospitalizations Than All Other Diabetic Complications Combined...
Aaron Vinik, MD, Ph.D., Endocrinologist, Diabetic Neuropathies, February 5, 2018
Pain has a significant impact on individuals in the United States and is more prevalent than diabetes, heart disease, and cancer combined. The CDC warns that the failure to diagnose both painful and painless neuropathy accurately can potentially lead to amputations of the toes, feet, or legs. While primary care providers are crucial in managing chronic pain, there is a notable gap in emphasizing the value of non-opioid alternatives among clinicians and insurance companies. Diabetic Neuropathy (DN) has two forms of peripheral neuropathy due to diabetes mellitus, which often coexist within the same diabetic patient. Around 50% of patients may experience symptomatic or painful neuropathy (small fiber), while up to 50% may exhibit asymptomatic or insensate neuropathy (large fiber). Both forms, whether painful or asymptomatic, present substantial challenges for patients, carrying morbidity and mortality risks that can significantly alter their lives.
(Painful) Small Fiber Neuropathy Can Only be Verified with Thermal Thresholds or Skin Biopsies.
Aaron Vinik, MD, Ph.D., Endocrinologist, Diabetic Neuropathies, February 5, 2018
DN is not well-understood due to the lack of standardized diagnosis methods. The existing methods are subjective and tend to diagnose DN when it's already well-established. Early and objective diagnosis is crucial for managing care. Technological advances and all-natural supplements like Dr. A. Vinik MD PhD nerve health supplements have helped people with diabetes live longer and healthier lives with fewer complications.
(Painless) Diabetic Large Nerve Fiber Dysfunction, as Measured by Vibration, Predicts Foot Ulceration, Amputation, and Mortality.
https://care.diabetesjournals.org/content/32/10/1896
Dementia and Diabetes
Our self-administered test can be given remotely or in-clinic. This 10-min test will show if a person is having problems with thinking, learning, and remembering. Learn more.
Digital Cognitive Assessments
At Diabetes Testing Centers™, we understand the importance of comprehensive assessments for individuals managing diabetes. There is a known correlation between being overweight, having Type 2 diabetes, and an increased risk of developing Dementia and Alzheimer's disease. Some researchers use the term Type 3 diabetes to describe the theory that dysfunction in insulin resistance and insulin-like growth factors in the brain may be a cause of Alzheimer's disease. Our latest innovation takes a unique approach – introducing our digital Cognitive Assessments, a breakthrough solution that requires no hardware, ensuring a hassle-free experience for healthcare providers and patients.
Unlike traditional pen and paper tests, our digital Cognitive Assessments are a solution for long-term cognitive monitoring. The test takes 5-10 minutes to complete and has been clinically validated to evaluate eight aspects of cognitive function. The evaluation provides normal ranges for age and can be self-administered by the patient. It allows for in-office or remote testing, tracks longitudinal results, and is highly reimbursable by medical payers. Conducting these assessments before initiating treatment establishes a baseline for comparison and enables healthcare providers to adjust treatment plans if needed to minimize cognitive side effects.
80% of People with Alzheimer's Have Type 2 Diabetes or Insulin Resistance
Why a Digital Cognitive Assessment?
Compared to the traditional pen-and-paper Montreal Cognitive Assessment (MoCA), our Cognitive Assessment has tested over half a million people to date and offers several advantages:
1. Standardization: Using digital administration can increase consistency in test presentation and results.
2. Automated Scoring: Eliminates scorer subjectivity and reduces the potential for human error in tallying results.
3. Accessibility: Can be taken remotely, increasing access for individuals who cannot travel to a clinic.
4. Efficiency: Automating the administration and scoring process saves time for administrators and patients.
5. Data Management: It is easier to store, track, and retrieve patient data for longitudinal monitoring.
6. Point-of-Care: Immediate feedback and results, which can be beneficial for clinicians and patients alike.
7. Environmental Impact: Reduces the use of paper, contributing to environmentally friendly practices.
Each assessment tool has its strengths, and medical providers typically select the tool that best fits their clinical context. One patient tested can pay for an unlimited amount of tests monthly.
Take Our Free Cognitive Assessment
Click here to see if any products or services are good for your practice.
